We’re excited to announce our Malta expansion is complete!
We will be returning to our 658 Malta location beginning Monday, August 27, 2018.
- Posted on: Jul 24 2018
We will be returning to our 658 Malta location beginning Monday, August 27, 2018.
This retrospective study compared the outcomes of patients who underwent either standard Dresden or accelerated corneal collagen cross-linking (CXL) for keratoconus. Source: AAO
This single-masked, prospective study compared the performance of 2 types of sutures for sclerotomy closure after pars plana vitrectomy (PPV): plain gut and polyglactin 910. Source: AAO
Findings from 2 late-stage trials hint that abicipar pegol performs on par with ranibizumab for neovascular AMD, but requires half the injections. Source: AAO
This week, male crabs stalk their prey’s movements, a new dry eye drug faces off with Allergan’s Restasis in a phase 2 trial and neckties restrict blood flow to the brain. Source: AAO
In this observational cross-sectional analysis, investigators evaluated the association between macula vascular density assessed by OCT angiography (OCT-A) and central visual field (VF) results. Source: AAO
This study describes the effect of heat and ice on ptosis in patients with myasthenia gravis (MG). Source: AAO
This study retrospectively evaluated the melanoma-specific mortality among patients who underwent a biopsy for posterior uveal melanoma. Source: AAO
This multicenter, open-label, prospective analysis evaluated the long-term safety and efficacy of the Kamra small-aperture intracorneal inlay. Source: AAO
Oyster Point Pharma reported positive preliminary results from a phase 2b trial testing their novel drug for dry eye disease. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »